Loading clinical trials...
Loading clinical trials...
A Phase II Study of G3139 in Combination With Doxorubicin in Advanced Hepatocellular Carcinoma
Conditions
Interventions
oblimersen sodium
doxorubicin hydrochloride
Locations
3
Canada
British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
Start Date
October 1, 2002
Primary Completion Date
January 1, 2009
Completion Date
April 1, 2009
Last Updated
November 8, 2017
NCT06345508
NCT07447050
NCT06440005
NCT06447064
NCT05727787
NCT07295262
Lead Sponsor
University Health Network, Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions